Paris, France
Paris, France
SEARCH FILTERS
Time filter
Source Type

The present invention relates to compositions and methods for the treatment of Parkinsons disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Parkinsons disease and related disorders targeting the alphasynuclein aggregation network. In particular, the invention relates to compounds which, alone or in combination(s), can effectively protect neuronal cells from alpha-synuclein aggregates. The invention also relates to methods of producing a drug or a drug combination for treating Parkinsons disease and to methods of treating Parkinsons disease or a related disorder.


Patent
Pharnext | Date: 2017-03-08

The present invention relates to compositions and methods for the treatment of diabetic neuropathies. More particularly, this invention relates to compositions and methods for promoting nerve regeneration in a subject suffering from, or at risk of suffering from a diabetic neuropathy, and for protecting nervous system cells against the stresses resulting from the perturbation of glucose homeostasis. More specifically, the present invention relates to novel single or combination therapies for diabetic neuropathies, comprising diabetic peripheral neuropathy, diabetic proximal neuropathy, diabetic autonomic neuropathy and diabetic focal neuropathy, based on restoring dorsal root ganglion neurons and other nerves integrity.


The present invention relates to compositions and methods for the treatment of the mechanical neuronal insu


Patent
Pharnext | Date: 2016-12-27

The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.


The present invention relates to combinations and methods for the treatment of neurological disorders related Amyloid beta toxicity and/or neuronal death and/or glucose impaired neuronal metabolism. More specifically, the present invention relates to novel combinatorial therapies of Alzheimers disease, Alzheimers disease related disorders, frontotemporal dementia, Parkinsons disease, Lewy body dementia, Huntingtons disease, peripheral neuropathies, alcoholism or alcohol withdrawal, neurological manifestations of drug abuse or drug abuse withdrawal, amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, epilepsy, traumatic brain injury or brain ischemic events based on baclofen, acamprosate and at least one medium chain triglyceride.


Patent
Pharnext | Date: 2016-07-18

The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.


Patent
Pharnext | Date: 2016-04-25

The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.


Patent
Pharnext | Date: 2016-02-01

The present invention relates to compositions and methods for the treatment of Parkinsons disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Parkinsons disease and related disorders targeting the alpha-synuclein aggregation network. In particular, the invention relates to compounds which, alone or in combination(s), can effectively protect neuronal cells from alpha-synuclein aggregates. The invention also relates to methods of producing a drug or a drug combination for treating Parkinsons disease and to methods of treating Parkinsons disease or a related disorder.


Patent
Pharnext | Date: 2016-01-25

The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.


The present invention relates to compositions and methods for controlling glycaemia in a mammalian in need thereof. The present invention relates to compositions and methods for the treatment of diabetes disease and related disorders. More specifically, the present invention relates to novel therapies or combinatorial therapies of diabetes and related disorders, based on compositions controlling the blood glucose level.

Loading Pharnext collaborators
Loading Pharnext collaborators